Evidence map›Paper›PMID 31768061›Full record

ArticleNature methods2020

An antibody for analysis of autophagy induction.

Wensheng Tian, Reham Alsaadi, Zhihao Guo, Alena Kalinina, Micaël Carrier, Marie-Eve Tremblay, Baptiste Lacoste, Diane Lagace, Ryan C Russell

Abstract read
PubMed Publisher
In one paragraph

Article in Nature methods, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 84 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. mCell · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Cell Death: Mechanisms and Potential Targets in Breast Cancer Therapy.International journal of molecular sciences · 2024
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Studying Autophagy in Microglia: Overcoming the Obstacles.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Wensheng TianDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Reham Alsaadi *Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Zhihao Guo *Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.ORCID http://orcid.org/0000-0002-8186-8447
Alena KalininaDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Micaël CarrierAxe Neurosciences, Centre de Recherche du CHU de Québec, Université Laval, Québec City, Québec, Canada.ORCID http://orcid.org/0000-0002-0658-2828
Marie-Eve TremblayAxe Neurosciences, Centre de Recherche du CHU de Québec, Université Laval, Québec City, Québec, Canada.
Baptiste LacosteDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.ORCID http://orcid.org/0000-0002-1922-8801
Diane LagaceDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Ryan C RussellDepartment of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada. ryan.russell@uottawa.ca.ORCID http://orcid.org/0000-0003-3364-8869
University of Ottawa · CAUniversité Laval · CA

Funding

CIHR PJT153034
6 · The paper itself

Abstract

Autophagy is a degradative program that maintains cellular homeostasis. Autophagy defects have been described in numerous diseases. However, analysis of autophagy rates can be challenging, particularly in rare cell populations or in vivo, due to limitations in currently available tools for measuring autophagy induction. Here, we describe a method to monitor autophagy by measuring phosphorylation of the protein ATG16L1. We developed and characterized a monoclonal antibody that can detect phospho-ATG16L1 endogenously in mammalian cells. Importantly, phospho-ATG16L1 is only present on newly forming autophagosomes. Therefore, its levels are not affected by prolonged stress or late-stage autophagy blocks, which can confound autophagy analysis. Moreover, we show that ATG16L1 phosphorylation is a conserved signaling pathway activated by numerous autophagy-inducing stressors. The described antibody is suitable for western blot, immunofluorescence and immunohistochemistry, and measured phospho-ATG16L1 levels directly correspond to autophagy rates. Taken together, this phospho-antibody represents an exciting tool to study autophagy induction.

Indexed as

AutophagyAnimalsAntibodiesCarrier ProteinsHumansPhosphorylationAntibodiesCarrier Proteins

Identifiers

PMID31768061
OpenAlexW2990730777

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.